Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib

Br J Haematol. 2024 Jun;204(6):2508-2511. doi: 10.1111/bjh.19483. Epub 2024 Apr 25.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Histiocytosis, Langerhans-Cell* / drug therapy
  • Humans
  • Middle Aged
  • Neurodegenerative Diseases / drug therapy
  • Proto-Oncogene Proteins B-raf / genetics
  • Vemurafenib* / therapeutic use

Substances

  • Proto-Oncogene Proteins B-raf
  • Vemurafenib